Position in ABBV
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,313,595
+$460,127 QoQ
Shares Held
13,168
+0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#1,579
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Klingman & Associates, LLC holds $15,277,947 across 11 Drug Manufacturers - General names. ABBV ranks #2 (21.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,448 | $4,431,268 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
13,168 | $3,313,595 | |
| 3 | LLY |
ELI LILLY & Co
|
2,410 | $2,890,626 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,463 | $1,344,495 | |
| 5 | AMGN |
Amgen Inc
|
2,140 | $774,936 | |
| 6 | NVS |
Novartis AG
|
4,523 | $708,844 | |
| 7 | PFE |
Pfizer Inc
|
28,237 | $679,946 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,664 | $336,569 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,313,595 | 13,168 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $2,853,468 | 13,120 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,008,756 | 13,168 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,944,725 | 12,718 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $2,423,083 | 13,054 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $2,447,822 | 11,683 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,991,483 | 11,207 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $2,303,604 | 11,665 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,474,385 | 8,596 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,509,973 | 8,292 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,279,277 | 8,255 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $1,228,254 | 8,240 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,103,842 | 8,193 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $1,272,728 | 7,986 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $1,284,314 | 7,947 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,054,756 | 7,859 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,202,918 | 7,854 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,290,395 | 7,960 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $687,561 | 5,078 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $540,536 | 5,011 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $558,018 | 4,954 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $527,788 | 4,877 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $517,213 | 4,827 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $422,796 | 4,827 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $372,102 | 3,790 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $288,760 | 3,790 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||